Biopharma Firm Urges Chancery To Ax Cholesterol Drug Suit
Biopharmaceutical company Esperion Therapeutics Inc. told a Delaware vice chancellor Wednesday that an investor has not shown evidence supporting allegations that company officers purposely misled the public about the prospects of...To view the full article, register now.
Already a subscriber? Click here to view full article